Copanlisib Intravenous and Inotuzumab ozogamicin Intravenous
Determining the interaction of Copanlisib Intravenous and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: copanlisib
Brand name: Aliqopa
Synonyms: Copanlisib
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Copanlisib Intravenous-Inova
- Copanlisib Intravenous-Inova 4/1 topical
- Copanlisib Intravenous-Inova 8/2 topical
- Copanlisib Intravenous-Inova ACT
- Copanlisib Intravenous-Inrebic
- Copanlisib Intravenous-Inspra
- Inotuzumab ozogamicin Intravenous-Copaxone
- Inotuzumab ozogamicin Intravenous-Cope
- Inotuzumab ozogamicin Intravenous-Copegus
- Inotuzumab ozogamicin Intravenous-Copiktra
- Inotuzumab ozogamicin Intravenous-CoQ10 coenzyme Q-10
- Inotuzumab ozogamicin Intravenous-Coral Calcium